Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI)

Journal of Clinical Immunology

Volumn 33, Issue 1, 2013, Pages 68-73

  Koopmans, Wikke ^a,b   Woon, See Tarn ^a,b   Brooks, Anna E S ^b,c   Dunbar, P Rod ^b,c   Browett, Peter ^b   Ameratunga, Rohan ^a,b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

C104R mutation; CVID; Infection; TACI

Indexed keywords

ANTIBIOTIC AGENT; C104R PROTEIN; DIPHTHERIA TETANUS VACCINE; GENOMIC DNA; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; PROTEIN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; UNCLASSIFIED DRUG; TNFRSF13B PROTEIN, HUMAN;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOPENIA; DIPHTHERIA; FAMILY; FEMALE; GENE MUTATION; GENOTYPE; HAEMOPHILUS INFECTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA VACCINATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; PHENOTYPIC VARIATION; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; SEGREGATION ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TETANUS; THROMBOCYTOPENIA; UPPER RESPIRATORY TRACT INFECTION; VERY ELDERLY; WILD TYPE; CHILD; CHROMOSOME SEGREGATION; GENE DOSAGE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; METHODOLOGY; PEDIGREE; POINT MUTATION;

ADULT; AGED, 80 AND OVER; CHILD; CHROMOSOME SEGREGATION; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PEDIGREE; POINT MUTATION; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN;

MLCS; MLOWN;

EID: 84876434414     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9793-x     Document Type: Article

References (37)

1. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190-7.
2. Oksenhendler E, Gerard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46(10):1547-54.
3. Ameratunga R, Becroft DM, Hunter W. The simultaneous presentation of sarcoidosis and common variable immune deficiency. Pathology. 2000;32(4):280-2.
4. Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol. 2006;117(4):740-6.
5. Bacchelli C, Buckridge S, Thrasher AJ, Gaspar HB. Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency. Clin Exp Immunol. 2007;149 (3):401-9.
6. Finck A, Van der Meer JW, Schaffer AA, Pfannstiel J, Fieschi C, Plebani A, et al. Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q. Eur J Hum Genet. 2006;14 (7):867-75.
7. Salzer U, Gutenberger S, Bossaller L, Schlesier M, Grimbacher B, Eibel H, et al., editors. Finally found: human BAFF-R deficiency causes CVID. XIth Meeting of the European Society for Immunodeficiencies; 2004 21-24 October; Versailles.
8. Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37(8):820-8.
9. Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005;37(8):829-34.
10. Volanakis JE, Zhu ZB, Schaffer FM, Macon KJ, Palermos J, Barger BO, et al. Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J Clin Investig. 1992;89(6):1914-22.
11. Olerup O, Smith CI, Bjorkander J, Hammarstrom L. Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc Natl Acad Sci U S A. 1992;89 (22):10653-7.
12. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R, et al. Homozygous loss of ICOS is associated with adultonset common variable immunodeficiency. Nat Immunol. 2003;4 (3):261-8.
13. van Zelm MC, Smet J, Adams B, Mascart F, Schandene L, Janssen F, et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Investig. 2010;120(4):1265-74.
14. van Zelm MC, Reisli I, van der Burg M, Castano D, van Noesel CJ, van Tol MJ, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med. 2006;354(18):1901-12.
15. Kuijpers TW, Bende RJ, Baars PA, Grummels A, Derks IA, Dolman KM, et al. CD20 deficiency in humans results in impaired T cellindependent antibody responses. J Clin Investig. 2010;120(1):214-22.
16. Thiel J, Kimmig L, Salzer U, Grudzien M, Lebrecht D, Hagena T, et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol. 2012;129(3):801-10.e6.
17. Garibyan L, Lobito AA, Siegel RM, Call ME, Wucherpfennig KW, Geha RS. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). J Clin Investig. 2007;117(6):1550-7.
18. Poodt AE, Driessen GJ, de Klein A, van Dongen JJ, van der Burg M, de Vries E. TACI mutations and disease susceptibility in patients with common variable immunodeficiency. Clin Exp Immunol. 2009;156(1):35-9.
19. Salzer U, Bacchelli C, Buckridge S, Pan-Hammarstrom Q, Jennings S, Lougaris V, et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood. 2009;113(9):1967-76.
20. Detkova D, Martinez-Pomar N, Arostegui J, Escobar D, Ferrer J, Serra A, et al. Role of the p.C104R variant of TNFRSF13B encoding TACI in patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 2008;150(1):158.
21. Pan-Hammarstrom Q, Salzer U, Du L, Bjorkander J, Cunningham-Rundles C, Nelson DL, et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet. 2007;39(4):429-30.
22. Mohammadi J, Liu C, Aghamohammadi A, Bergbreiter A, Du L, Lu J, et al. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J Clin Immunol. 2009 Jul 23.
23. Speletas M, Mamara A, Papadopoulou-Alataki E, Iordanakis G, Liadaki K, Bardaka F, et al. TNFRSF13B/TACI alterations in greek patients with antibody deficiencies. J Clin Immunol. 2011 May 6.
24. Ameratunga R, Woon ST, Neas K, Love DR. The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review. Allergy Asthma Clin Immunol. 2010;6 (1):12.
25. Ferry BL, Jones J, Bateman EA, Woodham N, Warnatz K, Schlesier M, et al. Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method. Clin Exp Immunol. 2005;140(3):532-9.
26. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77-85.
27. Ameratunga R, Lederman HM, Sullivan KE, Ochs HD, Seyama K, French JK, et al. Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr. 1997;131(1 Pt 1):147-50.
28. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-24.
29. Salzer U, Birmelin J, Bacchelli C, Witte T, Buchegger-Podbielski U, Buckridge S, et al. Sequence analysis of TNFRSF13b, encoding TACI, in patients with systemic lupus erythematosus. J Clin Immunol. 2007;27(4):372-7.
30. Sarantopoulos A, Tselios K, Skendros P, Bougiouklis D, Theodorou I, Boura P. Genetic polymorphism study of regulatory B cell molecules and cellular immunity function in an adult patient with common variable immunodeficiency. Hippokratia. 2008;12 (3):188-90.
31. Bacchelli C, Buckland KF, Buckridge S, Salzer U, Schneider P, Thrasher AJ, et al. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. J Allergy Clin Immunol. 2011;127(5):1253 e13-9 e13.
32. Thierry-Carstensen B, Jordan K, Uhlving HH, Dalby T, Sorensen C, Jensen AM, et al. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Vaccine. 2012;30(37):5464-71.
33. Wernette CM, Frasch CE, Madore D, Carlone G, Goldblatt D, Plikaytis B, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol. 2003;10(4):514-9.
34. Ameratunga SN, Lennon DR, Entwistle B, Robinson E, Ameratunga RV. The immunogenicity of Haemophilus influenzae:meningococcal protein conjugate vaccine in Polynesian and non-Polynesian New Zealand infants. J Paediatr Child Health. 1997;33(2):138-41.
35. Lee JJ, Jabara HH, Garibyan L, Rauter I, Sannikova T, Dillon SR, et al. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. J Allergy Clin Immunol. 2010;126(6):1234 e2-41 e2.
36. Wehr C, Eibel H, Masilamani M, Illges H, Schlesier M, Peter HH, et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol. 2004;113(2):161-71.
37. Warnatz K, Wehr C, Drager R, Schmidt S, Eibel H, Schlesier M, et al. Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology. 2002;206(5):502-13.